Rising temperatures are expected to increase the number of cases of Lyme disease in the United States by more than 20% by mid-century.
Ticks capable of transmitting Lyme disease and other tick-borne illnesses have been identified in dozens of places across the US where the pests had never previously been recorded.
Accurate and rapid diagnostics methods are needed to inform initial clinical decision making for patients with hip monoarthritis.
Research might explain why lingering symptoms after therapy for treating Lyme disease occur.
During the treatment for chronic Lyme disease, serious bacterial infections have been documented.
Polyphenols (baicalein, luteolin, and rosmarinic acid) and fatty acids (monolaurin and 10-HAD), and micronutrients (iodine and vitamins D3 and C) in combination with doxycycline were effective anti-borreliae substrates
Data from the Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) trial assessed whether longer term use of certain antibiotics resulted in improvements in health-related quality of life after open-label treatment with ceftriaxone.
Additional symptom identified for early treatment of this potentially serious bacterial infection.
In the United States, the highest outpatient incidence of Lyme disease was seen among boys aged 5 to 9 years and adults aged 60 to 64 years
Rheumatology Advisor Articles
- One-Session Intervention for Hand OA Improved Grip Strength, Patient Satisfaction
- Exercise, TNFi Provide Differential Benefits for Cardiovascular Health in Rheumatoid Arthritis
- Improving RA Diagnosis With Use of Anti-ACPAs
- Anti-Drug Antibody Incidence Risk in RA Increases Over Time With Adalimumab, Infliximab
- MBDA Scores Reflect Response to Rituximab Treatment in Rheumatoid Arthritis
- Circadian Rhythm in Rheumatoid Arthritis: Using Chronotherapy to Improve Outcomes
- Inflammatory Arthritis and the Gut Microbiome: Do Microbes Hold the Key to New Treatments?
- Examining Insurance Complications in the Shared Decision Making Process for Rheumatoid Arthritis
- Filgotinib Safe, Effective for Treatment of Active Ankylosing Spondylitis
- FDA Fast Track Designation Granted for Investigational Osteoarthritis Treatment
- Ultrasonography in Gout: Potential Applications for Diagnosis and Patient Monitoring
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information
- Immunogenicity of Golimumab Validated Using Novel Anti-Drug Antibody Detection Assay
- Poor Vitamin K Status Linked to Low BMD, Increased Fracture Risk in ESRD
- Most Insured Patients Not Using Online Portals